NR1H4 and metabolic dysfunction-associated steatohepatitis: Furthermore, it was found that the intake of probiotics through farnesoid X receptor (FXR), bile acid receptor, and KO mice induced metabolic dysfunction-associated steatohepatitis (MASH) through anti-inflammatory effects by removing liver lymphocyte infiltration and reducing liver fat content [37].